Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

SPIRIVA RESPIMAT

TIOTROPIUM BROMIDE

Standard Dose
2.5MCG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SPIRIVA RESPIMAT is listed in Drugs@FDA under application 207070 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TIOTROPIUM BROMIDE Form and strength SPRAY;INHALATION - 2.5MCG Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2015-09-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview SPIRIVA RESPIMAT is listed in Drugs@FDA under application 207070 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TIOTROPIUM BROMIDE Form and strength SPRAY;INHALATION - 2.5MCG Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2015-09-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.